Earnings Results: Pfizer’s stock drops as earnings fall sharply amid lower sales for its COVID products

Pfizer’s stock was down premarket as earnings hit by lower demand for its COVID products.

Previous post The Ratings Game: Rivian’s stock has been rocketing, and this analyst now urges a pause
Next post : Nio’s July deliveries double, but stock set to snap long winning streak